Carl Zeiss Meditec AG (AFX)

Industry Medical Instruments & Supplies

This stock can be held in an Investment ISA and an Investment Account
Sell

Buy

arrow-up€ (+%)

Carl Zeiss Meditec AG offers end-to-end solutions for the diagnosis and treatment of ophthalmic diseases, including implants and consumables. It provides visualization solutions in microsurgery. It offers its solutions to physicians and hospitals.
Prices updated at 15 May 2025, 06:54
| Prices minimum 15 mins delay
|
Prices in EUR

Most recent dividend payment

0.600
Cash Dividend
27 Mar 2025
23 Jan 2025
28 Mar 2025
31 Mar 2025

Total dividend yield

Created with Highcharts 7.2.2Total yield (%)Total yield (%)2021202220232024202502468

Dividend history and forecast data table

YearDividend per shareDividend growth (%)
20250.6000-
20241.1000-
20231.10000.22
20220.90000.80
20210.5000-0.23
20200.65000.18
20190.5500-
20180.55000.31
20170.42000.11
20160.3800-0.05

Total dividend yield data table

YearDividend yield (%)Buyback yield (%)Total yield (%)
20250.99-0.99
20242.423.776.19
20231.11-1.11
20220.76-0.76
20210.27-0.27
20200.60-0.60
20190.48-0.48
20180.81-0.81
20170.81-0.81
20161.09-1.09

Dividend per share

Created with Highcharts 7.2.2Dividend per shareDividend per share2021202220232024202500.250.50.7511.25

% of earnings paid to shareholders

Created with Highcharts 7.2.2Payout ratio (%)Payout ratio (%)20212022202320242025020406080

Dividend per share data table

YearDividend per share
20250.6000
20241.1000
20231.1000
20220.9000
20210.5000
20200.6500
20190.5500
20180.5500
20170.4200
20160.3800

% of earnings paid to shareholders data table

YearPayout ratio (%)
202562.15
202454.73
202333.85
202227.36
202118.94
202047.45
201930.73
201839.01
201726.75
201631.40
Latest Financial Report as of 13 May 2025
Dividend amount and dividend per share are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.